(1 - 4 von 10
)
Enspryng reduces relapse in NMOSD subgroup - Healiowww.healio.com › news › neurology › enspryng-re...
www.healio.com
vor 4 Tagen · ... Chugai], which inhibits IL-6 signaling, are sustained over time,” Osamu Okuda, president and CEO of Chugai, said in a press release.
Chugai's Hemlibra® Gains Positive CHMP Opinion in Severe ...apnews.com › ...
apnews.com
· Osamu Okuda. “Hemlibra is co-promoted by Chugai and Roche in Germany, France, and the United Kingdom, as is the case with the anti-rheumatic ...
sortiert nach Relevanz / Datum